---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-001253"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2024-03-01T23:59:59+00:00"
generated_at: "2026-06-05T05:23:32.330068+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma receives Nasdaq delisting notice; stock at $0.10 or less for 10 days

## Summary
- Nasdaq staff determined common stock bid price <= $0.10 for ten consecutive days as of Feb 27, 2024.
- Company appealed on Feb 28, 2024; hearing scheduled for April 25, 2024 stays delisting.
- Plans 40-for-1 reverse stock split after mailing definitive info statement to regain bid price compliance.
- If appeal not filed by March 6, trading would be suspended March 8 and a Form 25-NSE filed.

## SEC filing metadata
- accession: 0001683168-24-001253
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2024-03-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316824001253/0001683168-24-001253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316824001253/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-001253
- JSON: https://secwatch.observer/filing/0001683168-24-001253.json
- Plain text: https://secwatch.observer/filing/0001683168-24-001253.txt

## Key facts
- Listing & Compliance Notices
  Sunshine Biopharma Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5810(c)(3)(A)(iii)
  source text: February 28, 2024, the Company received a notification letter from Nasdaq advising that Nasdaq’s staff had determined that as of February 27, 2024, the Company’s common stock had a closing bid price of $0.10 or less for ten consecutive trading days and accordingly, the Company was subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). Accordingly, Nasdaq determined to remove the Company’s securities from listing and registration on The Nasdaq Stock Market, subject to the procedures set forth in the Nasdaq Listing Rule 5800 Series which prov
  evidence_url: https://www.sec.gov/Archives/edgar/data/1402328/000168316824001253/0001683168-24-001253-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.